Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.9 AUD | -1.06% | -0.07% | -7.00% |
Apr. 29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |